EASY BIO,Inc.

KOSDAQ:A353810 Stock Report

Market Cap: ₩171.4b

EASY BIOInc Past Earnings Performance

Past criteria checks 3/6

EASY BIOInc has been growing earnings at an average annual rate of 27.4%, while the Food industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 41% per year. EASY BIOInc's return on equity is 23.8%, and it has net margins of 4.6%.

Key information

27.41%

Earnings growth rate

27.69%

EPS growth rate

Food Industry Growth10.52%
Revenue growth rate41.00%
Return on equity23.82%
Net Margin4.63%
Last Earnings Update31 Mar 2025

Recent past performance updates

Statutory Profit Doesn't Reflect How Good EASY BIOInc's (KOSDAQ:353810) Earnings Are

Mar 28
Statutory Profit Doesn't Reflect How Good EASY BIOInc's (KOSDAQ:353810) Earnings Are

Recent updates

Investors Continue Waiting On Sidelines For EASY BIO,Inc. (KOSDAQ:353810)

May 26
Investors Continue Waiting On Sidelines For EASY BIO,Inc. (KOSDAQ:353810)

EASY BIOInc (KOSDAQ:353810) Seems To Use Debt Quite Sensibly

Mar 18
EASY BIOInc (KOSDAQ:353810) Seems To Use Debt Quite Sensibly

EASY BIO,Inc.'s (KOSDAQ:353810) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Dec 17
EASY BIO,Inc.'s (KOSDAQ:353810) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Does EASY BIOInc (KOSDAQ:353810) Have A Healthy Balance Sheet?

Dec 11
Does EASY BIOInc (KOSDAQ:353810) Have A Healthy Balance Sheet?

EASY BIOInc (KOSDAQ:353810) Might Be Having Difficulty Using Its Capital Effectively

Nov 20
EASY BIOInc (KOSDAQ:353810) Might Be Having Difficulty Using Its Capital Effectively

We Think EASY BIOInc (KOSDAQ:353810) Can Stay On Top Of Its Debt

Aug 07
We Think EASY BIOInc (KOSDAQ:353810) Can Stay On Top Of Its Debt

Statutory Profit Doesn't Reflect How Good EASY BIOInc's (KOSDAQ:353810) Earnings Are

Mar 28
Statutory Profit Doesn't Reflect How Good EASY BIOInc's (KOSDAQ:353810) Earnings Are

Revenue & Expenses Breakdown

How EASY BIOInc makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A353810 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 25441,85920,47461,6603,072
31 Dec 24384,33119,60457,1963,034
30 Sep 24309,28819,98652,9903,022
30 Jun 24245,53217,33641,8242,863
31 Mar 24185,20116,47931,7632,526
31 Dec 23165,38515,54427,1852,487
30 Sep 23164,17513,00426,5962,448
30 Jun 23162,03711,93026,6912,430
31 Mar 23160,04910,58127,0232,516
31 Dec 22155,5579,13127,2312,426
30 Sep 22149,8699,40127,2212,270
30 Jun 22142,1489,56125,2672,079
31 Mar 22133,87710,05422,3921,837
31 Dec 21129,45810,87320,7681,744

Quality Earnings: A353810 has high quality earnings.

Growing Profit Margin: A353810's current net profit margins (4.6%) are lower than last year (8.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A353810's earnings have grown significantly by 27.4% per year over the past 5 years.

Accelerating Growth: A353810's earnings growth over the past year (24.2%) is below its 5-year average (27.4% per year).

Earnings vs Industry: A353810 earnings growth over the past year (24.2%) exceeded the Food industry -8.5%.

Return on Equity

High ROE: Whilst A353810's Return on Equity (23.82%) is high, this metric is skewed due to their high level of debt.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/02 09:05
End of Day Share Price 2025/06/02 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

EASY BIO,Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yu-jung HanDaishin Securities Co. Ltd.
Jun-Seo HeoEugene Investment & Securities Co Ltd.
Eui-Seob ShimNH Investment & Securities Co., Ltd.